Anti-LEF1 antibody [EPR2029Y] (ab137872)

ab137872 has been referenced in 10 publications.

• O'Malley DP  et al. Expression of LEF1 in mantle cell lymphoma. Ann Diagn Pathol 26:57-59 (2017). IHC-P ; Human . PubMed: 28038713
• Menter T  et al. Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas. Am J Clin Pathol 147:292-300 (2017). IHC ; Human . PubMed: 28395058
• Li P  et al. Clinical significance and biological role of Wnt10a in ovarian cancer. Oncol Lett 14:6611-6617 (2017). PubMed: 29163692
• Li FF  et al. Different effection of p.1125Val>Ala and rs11954856 in APC on Wnt signaling pathway. Oncotarget 8:70854-70864 (2017). PubMed: 29050326
• Dräger J  et al. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma. Oncotarget 8:3259-3273 (2017). IHC-P ; Human . PubMed: 27965462
• Siddiqi IN  et al. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol 29:570-81 (2016). IHC ; Human . PubMed: 26965583
• Tandon B  et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle? Leuk Lymphoma 56:3378-86 (2015). IHC ; Human . PubMed: 25860247
• Skokowa J  et al. Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. Nat Med 18:1550-9 (2012). PubMed: 23001182
• Tandon B  et al. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol 24:1433-43 (2011). IHC ; Human . PubMed: 21685909
• Geissinger E  et al. Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations. Haematologica 95:1697-704 (2010). IHC-P ; Human . PubMed: 20511667